Solventum Co. (NYSE:SOLV) Shares Acquired by Harbor Capital Advisors Inc.

Harbor Capital Advisors Inc. lifted its position in Solventum Co. (NYSE:SOLV) by 24.8% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 46,965 shares of the company’s stock after purchasing an additional 9,333 shares during the period. Harbor Capital Advisors Inc.’s holdings in Solventum were worth $3,103,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also recently added to or reduced their stakes in the company. Hollencrest Capital Management acquired a new position in shares of Solventum in the second quarter worth about $25,000. Modus Advisors LLC acquired a new position in Solventum in the 4th quarter worth about $25,000. Copeland Capital Management LLC purchased a new position in Solventum during the third quarter worth approximately $26,000. Mather Group LLC. acquired a new stake in Solventum in the third quarter valued at approximately $27,000. Finally, GHP Investment Advisors Inc. purchased a new stake in shares of Solventum in the second quarter valued at approximately $29,000.

Analyst Upgrades and Downgrades

A number of equities research analysts recently issued reports on SOLV shares. Morgan Stanley lifted their price target on shares of Solventum from $60.00 to $73.00 and gave the company an “equal weight” rating in a research note on Monday, November 11th. Wolfe Research assumed coverage on shares of Solventum in a research note on Thursday, September 26th. They set a “peer perform” rating for the company. Mizuho started coverage on Solventum in a report on Wednesday, December 4th. They issued a “neutral” rating and a $70.00 price objective on the stock. Stifel Nicolaus assumed coverage on Solventum in a report on Tuesday, October 8th. They set a “buy” rating and a $82.00 target price for the company. Finally, Piper Sandler lifted their price target on Solventum from $71.00 to $75.00 and gave the stock a “neutral” rating in a research note on Friday, November 8th. One equities research analyst has rated the stock with a sell rating, nine have issued a hold rating and one has issued a buy rating to the company’s stock. According to MarketBeat, Solventum has a consensus rating of “Hold” and an average target price of $68.29.

Solventum Stock Performance

NYSE SOLV opened at $67.19 on Friday. The company has a debt-to-equity ratio of 2.45, a current ratio of 1.15 and a quick ratio of 0.83. The stock’s fifty day moving average is $69.32 and its two-hundred day moving average is $64.80. Solventum Co. has a fifty-two week low of $47.16 and a fifty-two week high of $96.05.

Solventum Company Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.